Todays approval in the frontline consolidation phase, regardless of MRD status, allows us to reach more patients than ever with this transformative, first-in-class Bispecific T-cell Engager (BiTE) therapy, Jay Bradner, executive vice president of research and development and chief scientific officer at Amgen, said in a press release
Skip to content ABILITY Manufacturing Facilities R&D-Driven Custom Peptide Solutions Rigorous Quality Management Regulatory & Compliance Supply Chain Logistics Technical Support RESEARCH PEPTIDES GLP-1 receptor single-target agonists GLP-1-based multi-target receptor agonists Amylin receptor agonists Growth hormone axis regulatory peptides Gut function regulatory peptides Cytoprotective and tissue-repair peptides RESOURCE CENTER Quality Certificates Logistics Packaging Instructions Brochure Flyers FAQs NEWS Exhibition ABOUT US CONTACT US ABILITY Manufacturing Facilities R&D-Driven Custom Peptide Solutions Rigorous Quality Management Regulatory & Compliance Supply Chain Logistics Technical Support RESEARCH PEPTIDES GLP-1 receptor single-target agonists GLP-1-based multi-target receptor agonists Amylin receptor agonists Growth hormone axis regulatory peptides Gut function regulatory peptides Cytoprotective and tissue-repair peptides RESOURCE CENTER Quality Certificates Logistics Packaging Instructions Brochure Flyers FAQs NEWS Exhibition ABOUT US CONTACT US English English Korean Russian Portuguese Spanish Arabic Hindi Cytoprotective and tissue-repair peptides Home / Cytoprotective and tissue-repair peptides Search for: Search Products categories GLP-1 receptor single-target agonists GLP-1-based multi-target receptor agonists Amylin receptor agonists Growth hormone axis regulatory peptides Gut function regulatory peptides Cytoprotective and tissue-repair peptides Cytoprotective and tissue-repair peptides BPC-157 (Acetate Form) Read more Cytoprotective and tissue-repair peptides BPC-157 (Arginine Salt Form) Read more Cytoprotective and tissue-repair peptides TB500 Read more Scroll to Top Request a quote Name Phone Number Email Company Message Submit Inquiry Now Name Phone Email Address Message Send
The combination of these peptides has attracted scientific attention because researchers believe multi-pathway peptide blends may offer broader regenerative research applications compared to single-compound studies
If you notice these signs, seek medical help right away
Key Research Attributes Premium dual-peptide research blend: BPC-157 + TB-500 (10mg + 10mg) Studied extensively in tissue repair, healing, and regenerative biology research Explored deeply in systemic cell migration, angiogenesis, and deep tissue remodeling Investigated for connective tissue, tendon, ligament, and recovery-focused models Premium lyophilized format for maximum structural stability, shelf life, and measurement precision Intended strictly for in-vitro and controlled laboratory research use The BPC-157 + TB-500 combination continues to attract unprecedented interest within the global scientific community due to its highly complementary mechanisms and incredibly broad applicability in regenerative research
Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease 6
